Physician profile
Muhammad Ali
NPI 1801264353
$1,938.06
in general payments reported to CMS, 2019-2025
17 companies · $15.67 in 2025
The $15.67 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.47 · 2020: $251 · 2022: $260 · 2023: $1,212 · 2024: $184 · 2025: $15.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $912 · Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $911.98 |
| Food and Beverage | $499.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $966.98 | 2023 | Single Use Suction Valve (Sterile) |
| Astrazeneca Pharmaceuticals LP | $174.93 | 2019-2025 | Tagrisso, Fasenra |
| Glaxosmithkline, LLC. | $172.11 | 2020-2024 | Trelegy Ellipta, Arexvy, Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $132.31 | 2022-2023 | Glassia, Aralast |
| Grifols USA, LLC | $130.65 | 2023-2024 | Prolastin-C Liquid |
| Portola Pharmaceuticals, LLC | $124.35 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $45.32 | 2024 | Dupixent |
| Ethicon INC. | $30.17 | 2024 | Monarch Platform |
| Electromed, INC. | $23.88 | 2022 | |
| Melinta Therapeutics, LLC | $21.59 | 2023 | Rezzayo, Vabomere, Kimyrsa |
| Biogen, INC. | $19.39 | 2024 | Leqembi |
| Alexion Pharmaceuticals, INC. | $19.38 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $17.97 | 2023 | Uptravi |
| Mallinckrodt Hospital Products INC. | $15.89 | 2022 | |
| Travere Therapeutics, INC. | $15.75 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $14.15 | 2024 | Cios Spin |
| Shionogi INC | $13.24 | 2023 | Fetroja |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.